Molecular Formula | C19H15Cl2N3O2 |
Molar Mass | 388.25 |
Density | 1.412±0.06 g/cm3(Predicted) |
Boling Point | 605.4±55.0 °C(Predicted) |
Solubility | DMSO (Slightly), Methanol (Very Slightly) |
Appearance | Solid |
Color | Off-White to Pale Yellow |
pKa | 10.37±0.70(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,2-8°C |
In vitro study | CCMI (Compound 6) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.576 ml | 12.878 ml | 25.757 ml |
5 mM | 0.515 ml | 2.576 ml | 5.151 ml |
10 mM | 0.258 ml | 1.288 ml | 2.576 ml |
5 mM | 0.052 ml | 0.258 ml | 0.515 ml |
biological activity | CCMI is an effective and selective α7 nAChR forward allosteric regulator, which does not bind to α7 nAChR through positive binding sites and activate it, and can effectively positively regulate the current induced by agonists on α7 nAChR. CCMI has potential efficacy in neurological cognitive disorders. |
Target | α7 nAChR |